Dr Christopher Neal Conner, MD | |
1364 Clifton Rd Ne, Emory Univ Hospital Depart Of Interventional Radiology, Atlanta, GA 30322-1059 | |
(404) 712-2000 | |
Not Available |
Full Name | Dr Christopher Neal Conner |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 14 Years |
Location | 1364 Clifton Rd Ne, Atlanta, Georgia |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417239765 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 2011016067 (Missouri) | Secondary |
2085R0204X | Radiology - Vascular & Interventional Radiology | MD35006 (South Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Lee Memorial Hospital | Fort myers, FL | Hospital |
Gulf Coast Medical Center Lee Health | Fort myers, FL | Hospital |
Cape Coral Hospital | Cape coral, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Florida Radiology Leasing Llc | 1759327356 | 26 |
Florida Radiology Consultants P A | 3678471943 | 45 |
News Archive
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
In recent years, a common parasitic infection - as many as a third of the world's population may have it - has been linked to a range of psychiatric disorders, including schizophrenia and bipolar disorder, as well as behavioral dysregulation such as suicide attempts and car accidents.
Abbott has reported that its scientists are the first to discover a proprietary technology that combines the function and specificity of two or more monoclonal antibodies (mAbs) into one molecular entity that demonstrates drug-like properties and manufacturing feasibility.
I will talk about the simple but fundamental idea that allowed breaking the diffraction barrier in fluorescence microscopy as well as about MINFLUX nanoscopy, the latest development in the field that for the first time provides true molecular resolution with visible light and standard objective lenses.
› Verified 1 days ago
Entity Name | Florida Radiology Consultants P A |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518911668 PECOS PAC ID: 3678471943 Enrollment ID: O20031223000475 |
News Archive
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
In recent years, a common parasitic infection - as many as a third of the world's population may have it - has been linked to a range of psychiatric disorders, including schizophrenia and bipolar disorder, as well as behavioral dysregulation such as suicide attempts and car accidents.
Abbott has reported that its scientists are the first to discover a proprietary technology that combines the function and specificity of two or more monoclonal antibodies (mAbs) into one molecular entity that demonstrates drug-like properties and manufacturing feasibility.
I will talk about the simple but fundamental idea that allowed breaking the diffraction barrier in fluorescence microscopy as well as about MINFLUX nanoscopy, the latest development in the field that for the first time provides true molecular resolution with visible light and standard objective lenses.
› Verified 1 days ago
Entity Name | Florida Radiology Leasing Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1518907823 PECOS PAC ID: 1759327356 Enrollment ID: O20050706000059 |
News Archive
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
In recent years, a common parasitic infection - as many as a third of the world's population may have it - has been linked to a range of psychiatric disorders, including schizophrenia and bipolar disorder, as well as behavioral dysregulation such as suicide attempts and car accidents.
Abbott has reported that its scientists are the first to discover a proprietary technology that combines the function and specificity of two or more monoclonal antibodies (mAbs) into one molecular entity that demonstrates drug-like properties and manufacturing feasibility.
I will talk about the simple but fundamental idea that allowed breaking the diffraction barrier in fluorescence microscopy as well as about MINFLUX nanoscopy, the latest development in the field that for the first time provides true molecular resolution with visible light and standard objective lenses.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Christopher Neal Conner, MD 1364 Clifton Rd Ne, Emory Univ Hospital Dept Of Interventional Radiology, Atlanta, GA 30322-1059 Ph: (404) 712-2000 | Dr Christopher Neal Conner, MD 1364 Clifton Rd Ne, Emory Univ Hospital Depart Of Interventional Radiology, Atlanta, GA 30322-1059 Ph: (404) 712-2000 |
News Archive
LEO Pharma today announced that in a Phase III study, PEP005 (ingenol mebutate) Gel, the company's lead candidate for the topical treatment of actinic (solar) keratosis (AK) or pre-cancerous lesions, met its primary clinical endpoint of complete clearance of AK lesions in non-head locations.
In recent years, a common parasitic infection - as many as a third of the world's population may have it - has been linked to a range of psychiatric disorders, including schizophrenia and bipolar disorder, as well as behavioral dysregulation such as suicide attempts and car accidents.
Abbott has reported that its scientists are the first to discover a proprietary technology that combines the function and specificity of two or more monoclonal antibodies (mAbs) into one molecular entity that demonstrates drug-like properties and manufacturing feasibility.
I will talk about the simple but fundamental idea that allowed breaking the diffraction barrier in fluorescence microscopy as well as about MINFLUX nanoscopy, the latest development in the field that for the first time provides true molecular resolution with visible light and standard objective lenses.
› Verified 1 days ago
Omar Nabil Kallas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1364 Clifton Road, Department Of Radiology And Imaging Sciences, Atlanta, GA 30322 Phone: 404-778-3900 | |
Dr. Bijan Ghorashi, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 20 Glenlake Parkway, Kaiser Permanente Glenlake Medical, Atlanta, GA 30328 Phone: 404-365-0966 Fax: 606-666-6107 | |
Dr. George Oren Atkinson Jr., MD Radiology Medicare: Not Enrolled in Medicare Practice Location: Emory University Hospital, 1364 Clifton Road, Ne, Atlanta, GA 30322 Phone: 404-785-6547 Fax: 404-785-1216 | |
Dr. Fabio P Esteves, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1364 Clifton Rd Ne Radiology, Atlanta, GA 30322 Phone: 404-778-5586 | |
Amy J Figueroa, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Johnson Ferry Rd Ne, Atlanta, GA 30342 Phone: 404-851-8000 | |
Debora Lou Coursey-prah, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1968 Peachtree Rd Nw, Radiology Department, Atlanta, GA 30309 Phone: 404-605-5000 | |
Sachin Parikh, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1365 Clifton Rd Ne, Breast Imaging Center, Winship C, Atlanta, GA 30322 Phone: 404-778-1856 Fax: 404-712-7561 |